XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Gain/(Loss)
Beginning Balance at Dec. 31, 2022 $ (71,304,000)   $ 1,000 $ 40,402,000 $ (111,707,000)  
Beginning Balance, Shares at Dec. 31, 2022     84,165      
Temporary equity, Beginning balance at Dec. 31, 2022   $ 62,071,000        
Temporary equity, Beginning balance, Shares at Dec. 31, 2022   84,820,880        
Stock-based compensation expense 11,126,000     11,126,000    
Conversion of preferred stock to common stock as a result of the Merger, shares     2,442,852      
Conversion of preferred stock to common stock as a result of the Merger, shares   (84,820,880)        
Conversion of preferred stock to common stock as a result of the Merger, value 62,071,000     62,071,000    
Conversion of preferred stock to common stock as a result of the Merger, value   $ (62,071,000)        
Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001, Shares     1,571,433      
Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001 29,218,000     29,218,000    
Issuance of common shares from private placement (net of issuance costs), shares     596,363      
Issuance of common shares from private placement (net of issuance costs) 10,340,000     10,340,000    
Conversion of promissory notes into common stock, shares     590,031      
Conversion of promissory notes into common stock 3,245,000     3,245,000    
Conversion of Series C-2 Warrants into common stock, share     80,254      
Conversion of Series C-2 Warrants into common stock 442,000     442,000    
Conversion of promissory note warrants into common stock, shares     152,875      
Conversion of promissory note warrants into common stock 841,000     841,000    
Merger transaction costs (4,591,000)     (4,591,000)    
Restricted stock units net settlement, shares     143,960      
Restricted stock units net settlement (297,000)     (297,000)    
Reclassification of warrant liability to equity 216,000     216,000    
Net income (loss) (19,288,000)       (19,288,000)  
Temporary equity, Ending balance at Mar. 31, 2023   $ 0        
Temporary equity, Ending balance, Shares at Mar. 31, 2023   0        
Ending Balance at Mar. 31, 2023 22,019,000   $ 1,000 153,013,000 (130,995,000)  
Ending Balance, Shares at Mar. 31, 2023     5,661,933      
Beginning Balance at Dec. 31, 2022 (71,304,000)   $ 1,000 40,402,000 (111,707,000)  
Beginning Balance, Shares at Dec. 31, 2022     84,165      
Temporary equity, Beginning balance at Dec. 31, 2022   $ 62,071,000        
Temporary equity, Beginning balance, Shares at Dec. 31, 2022   84,820,880        
Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001 29,218,000          
Net income (loss) (30,211,000)          
Ending Balance at Sep. 30, 2023 12,159,000   $ 1,000 154,076,000 (141,918,000)  
Ending Balance, Shares at Sep. 30, 2023     5,684,873      
Beginning Balance at Mar. 31, 2023 22,019,000   $ 1,000 153,013,000 (130,995,000)  
Beginning Balance, Shares at Mar. 31, 2023     5,661,933      
Temporary equity, Beginning balance at Mar. 31, 2023   $ 0        
Temporary equity, Beginning balance, Shares at Mar. 31, 2023   0        
Stock-based compensation expense 463,000     463,000    
Adjustment to purchase accounting 3,000     3,000    
Merger transaction costs 40,000     40,000    
Net income (loss) (6,304,000)       (6,304,000)  
Ending Balance at Jun. 30, 2023 16,221,000   $ 1,000 153,519,000 (137,299,000)  
Ending Balance, Shares at Jun. 30, 2023     5,661,933      
Stock-based compensation expense 482,000     482,000    
Adjustment to purchase accounting 3,000     3,000    
Issuance of common stock (net of issuance costs) 72,000     72,000    
Issuance of common stock (net of issuance costs), shares     22,940      
Net income (loss) (4,619,000)       (4,619,000)  
Ending Balance at Sep. 30, 2023 12,159,000   $ 1,000 154,076,000 (141,918,000)  
Ending Balance, Shares at Sep. 30, 2023     5,684,873      
Beginning Balance at Dec. 31, 2023 8,157,000   $ 1,000 154,218,000 (146,064,000) $ 2,000
Beginning Balance, Shares at Dec. 31, 2023     5,754,505      
Stock-based compensation expense 414,000     414,000    
Issuance of common shares from private placement (net of issuance costs), shares     4,985,610      
Issuance of common shares from private placement (net of issuance costs) 7,905,000   $ 2,000 7,903,000    
Issuance of warrants in connection with the private placement 660,000     660,000    
Unrealized gain (loss) on investments (19,000)         (19,000)
Net income (loss) 130,000       130,000  
Ending Balance at Mar. 31, 2024 17,247,000   $ 3,000 163,195,000 (145,934,000) (17,000)
Ending Balance, Shares at Mar. 31, 2024     10,740,115      
Beginning Balance at Dec. 31, 2023 $ 8,157,000   $ 1,000 154,218,000 (146,064,000) 2,000
Beginning Balance, Shares at Dec. 31, 2023     5,754,505      
Issuance of common stock from exercise of stock options, shares 12,852          
Issuance of common stock to Graybug stockholders as a result of Merger and reset to par of $0.0001 $ 0          
Issuance of common stock from at-the-market offering (net of issuance costs), shares     101,522      
Issuance of common stock from at-the-market offering (net of issuance costs)     $ 319,000      
Net income (loss) (9,442,000)          
Ending Balance at Sep. 30, 2024 9,030,000   $ 3,000 164,529,000 (155,506,000) 4,000
Ending Balance, Shares at Sep. 30, 2024     10,761,917      
Beginning Balance at Mar. 31, 2024 17,247,000   $ 3,000 163,195,000 (145,934,000) (17,000)
Beginning Balance, Shares at Mar. 31, 2024     10,740,115      
Stock-based compensation expense 486,000     486,000    
Issuance of common stock from exercise of stock options 4,000     4,000    
Issuance of common stock from exercise of stock options, shares     1,091      
Issuance of common stock from at-the-market offering (net of issuance costs), shares     8,950      
Issuance of common stock from at-the-market offering (net of issuance costs) 47,000     47,000    
Unrealized gain (loss) on investments 8,000         8,000
Net income (loss) (3,954,000)       (3,954,000)  
Ending Balance at Jun. 30, 2024 13,838,000   $ 3,000 163,732,000 (149,888,000) (9,000)
Ending Balance, Shares at Jun. 30, 2024     10,750,156      
Stock-based compensation expense 781,000     781,000    
Issuance of common stock from exercise of stock options 16,000     16,000    
Issuance of common stock from exercise of stock options, shares     11,761      
Unrealized gain (loss) on investments 13,000         13,000
Net income (loss) (5,618,000)       (5,618,000)  
Ending Balance at Sep. 30, 2024 $ 9,030,000   $ 3,000 $ 164,529,000 $ (155,506,000) $ 4,000
Ending Balance, Shares at Sep. 30, 2024     10,761,917